T-VEC is an oncolytic virus therapy, a treatment that uses a virus to infect and kill cancer cells while avoiding normal, healthy cells. T-VEC is made from a genetically modified herpes virus, commonly known as the cold sore virus. The therapy is designed to replicate inside melanoma cells to kill those cells. It may also enhance the immune system's ability to fight cancer.

Sherry Xin Hsu, MD
Hematology & Oncology Specialist
Kaiser Permanente (Riverside Medical Center)

свернуть